INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “INSURANCE/HEALTH: Provides relative to formulary placement and cost-sharing requirements for certain generic drugs and biosimilars (EN NO IMPACT See Note)” Read the full text
Official title shown verbatim from the official record. Plain-language summary coming as coverage deepens. Not legal advice.
2026 Regular Session
Where it is
Show all 41 actions
Prefiled. · Feb 27, 2026
House
Under the rules, provisionally referred to the Committee on Insurance. · Feb 27, 2026
House
First appeared in the Interim Calendar on 2/27/2026. · Feb 27, 2026
House
Read by title, under the rules, referred to the Committee on Insurance. · Mar 9, 2026
House
Reported with amendments (10-0). · Apr 1, 2026
House
Read by title, amended, ordered engrossed, passed to 3rd reading. · Apr 7, 2026
House
Scheduled for floor debate on 04/09/2026. · Apr 8, 2026
House
Read by title, returned to the calendar. · Apr 9, 2026
House
Notice given. · Apr 9, 2026
House
Scheduled for floor debate on 04/13/2026. · Apr 9, 2026
House
Called from the calendar. · Apr 13, 2026
House
Read third time by title, amended, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate. · Apr 13, 2026
House
Received in the Senate. Read first time by title and placed on the Calendar for a second reading. · Apr 14, 2026
Senate
Read second time by title and referred to the Committee on Insurance. · Apr 15, 2026
Senate
Reported with amendments. · May 6, 2026
Senate
Committee amendments read and adopted. Read by title and referred to the Legislative Bureau. · May 7, 2026
Senate
Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. · May 11, 2026
Senate
Rules suspended. · May 18, 2026
Senate
Read by title and returned to the Calendar, subject to call. · May 18, 2026
Senate
Rules suspended. Called from the Calendar. · May 19, 2026
Senate
Senate floor amendments read and adopted. Read by title, passed by a vote of 33 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. · May 19, 2026
Senate
Received from the Senate with amendments. · May 20, 2026
House
Scheduled for concurrence on 05/26/2026. · May 25, 2026
House
Read by title, roll called, yeas 99, nays 0, Senate amendments rejected, conference committee appointment pending. · May 26, 2026
House
Notice House rejected the Senate amendments. · May 26, 2026
Senate
Senate conference committee members appointed: Talbot, Bass, and Harris. · May 26, 2026
Senate
Notice of Senate conferees appointed. · May 26, 2026
House
House conferees appointed: Turner, Firment, and Miller. · May 27, 2026
House
Notice House Conference Committee members appointed. · May 27, 2026
Senate
Conference Committee report received. Lies over under the rules. · May 29, 2026
House
Conference committee report received. · May 29, 2026
Senate
Scheduled for floor debate on 05/312026. · May 29, 2026
House
Conference Committee Report read, roll called, yeas 94, nays 0. The Conference Committee Report was adopted. · May 31, 2026
House
Notice House adopted the Conference Committee Report. · May 31, 2026
Senate
Conference Committee Report read; adopted by a vote of 36 yeas and 0 nays. · May 31, 2026
Senate
Notice of Senate adoption of Conference Committee Report. · May 31, 2026
House
Enrolled and signed by the Speaker of the House. · Jun 1, 2026
House
Signed by the President of the Senate. · Jun 1, 2026
Senate
Sent to the Governor for executive approval. · Jun 2, 2026
House
Signed by the Governor. Becomes Act No. 907. · Jun 12, 2026
House
Effective date: 08/01/2026. · Jun 12, 2026
House
The numbers
1
sponsor on the bill
Sponsors
Christopher Turner
Every fact on this page links to its source, starting with the official bill record. Last action: Effective date: 08/01/2026. (Jun 12, 2026).